(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

BD 227781 - Shigella Antiserum Polyvalent Group C2 for Serological Identification and Agglutination Testing

BD  # 227781 - Shigella Antiserum Polyvalent Group C2 for Serological Identification and Agglutination Testing
Part Number BD 227781
SKU Number CIA2544453
Sell Unit EACH
Ships Within Special Order
List Price $879.19
Enter a valid quantity
Product Description

BD 227781 - Shigella Antiserum Polyvalent Group C2 for Serological Identification and Agglutination Testing

The BD 227781 Shigella Antiserum Polyvalent Group C2 is a specialized in vitro diagnostic reagent designed for the accurate serological identification of Shigella Group C2 organisms. Developed by BD, a trusted leader in microbiology diagnostics, this antiserum contains carefully formulated antibodies that react specifically with Group C2 somatic antigens, enabling clear and reliable agglutination results.

This product is primarily used in clinical and public health laboratories to confirm the presence of Shigella species following culture isolation. Its formulation supports strong antigen-antibody interactions, producing visible agglutination that allows laboratory professionals to quickly determine the presence of target organisms. Manufactured under strict quality control standards, the reagent ensures consistency, sensitivity, and specificity across testing procedures.

Key Benefits

The BD 227781 antiserum delivers rapid and accurate identification of Shigella Group C2 strains, helping laboratories reduce diagnostic turnaround time and improve workflow efficiency. Its high specificity minimizes cross-reactivity, ensuring reliable results even in complex microbiological samples.

The ready-to-use liquid format simplifies testing procedures, eliminating preparation steps and reducing the risk of user error. Clear and distinct agglutination reactions enhance interpretability, allowing technicians to make confident diagnostic decisions.

By supporting precise pathogen identification, this product contributes to improved patient management, infection control, and effective outbreak response.

Compatibility and Applications

The BD 227781 Shigella Antiserum is fully compatible with standard slide agglutination testing methods used in microbiology laboratories. It works effectively with bacterial isolates cultured on selective and differential media such as MacConkey agar and other enteric culture media.

Typical applications include clinical microbiology laboratories, hospital diagnostic centers, public health agencies, and research institutions. It is widely used for routine stool culture analysis, confirmation of Shigella infections, and epidemiological surveillance of enteric diseases.

Usage Guidelines

Ensure the reagent is stored under recommended conditions and brought to room temperature before use. Gently mix the antiserum to achieve uniform consistency without introducing bubbles.

Place a small amount of the bacterial colony onto a clean glass slide, add a drop of the antiserum, and mix gently. Observe for visible agglutination within the specified time frame. A positive reaction indicates the presence of Shigella Group C2 antigens.

Always include appropriate control samples to validate test accuracy. Refer to the manufacturers instructions for detailed procedural guidance.

Certifications and Safety Standards

The BD 227781 antiserum is manufactured in compliance with internationally recognized quality standards, including ISO-certified production systems and Good Manufacturing Practices. These standards ensure consistent quality, safety, and reliability.

The product is intended for in vitro diagnostic use and aligns with regulatory requirements such as FDA clearance and CE marking where applicable. These certifications confirm adherence to strict safety and performance criteria for clinical laboratory use.

Comparison with Competitor Products

Compared to other Shigella antisera available on the market, the BD 227781 stands out for its consistent agglutination clarity and high specificity for Group C2 antigens. Competing products may show weaker reactions or higher cross-reactivity, which can complicate interpretation.

BDs expertise in microbiology diagnostics ensures rigorous validation and dependable performance. The products strong reaction profile and ease of use make it a preferred choice for laboratories requiring accurate and efficient serological identification.

Its reliability and compatibility with standard laboratory protocols provide a clear advantage over less standardized alternatives.

Typical User Profile and Application Scenarios

The BD 227781 Shigella Antiserum is primarily used by microbiologists, laboratory technicians, and clinical diagnosticians involved in bacterial identification and infectious disease testing. It is also utilized by public health professionals conducting outbreak investigations and surveillance.

Common scenarios include routine stool culture testing, confirmation of suspected Shigella infections, and monitoring of enteric disease outbreaks. Laboratories rely on this product to deliver accurate and timely results in high-demand environments.

Best Practices for Use and Maintenance

Store the antiserum at recommended temperatures and avoid exposure to extreme heat or freezing unless specified by the manufacturer. Always check the expiration date before use and discard any reagent that shows signs of contamination or degradation.

Use clean slides and sterile tools during testing to prevent cross-contamination. Minimize prolonged exposure of the reagent to air by promptly closing the container after use.

Following proper laboratory protocols and quality control procedures will help maintain consistent and reliable performance.

Regulatory and Safety Information

The BD 227781 Shigella Antiserum is intended for professional laboratory use only. Users should follow all biosafety and infection control guidelines when handling bacterial cultures and biological materials.

The product complies with relevant regulatory standards for in vitro diagnostic reagents, ensuring safe and reliable use in clinical and research environments. Proper disposal of used materials should be carried out according to biohazard waste regulations.

How to Order

Ordering the BD 227781 Shigella Antiserum Polyvalent Group C2 is simple through CIA Medical. Locate the product on the website, add it to your cart, and proceed through the secure checkout process.

For bulk orders, pricing inquiries, or additional support, contact CIA Medical customer service at (312) 275-5850. Their team is available to assist with your laboratory supply needs and ensure a smooth purchasing experience.

Related Products